Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.4K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

802
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
802
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

748
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
748
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

351
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
351
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

653
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
653
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

7
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
7

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immigration and epigenetic age acceleration in the health and retirement study: differences Between Hispanics and Non-Hispanics.

American journal of epidemiology·2026
Same author

Paid time off and cardiovascular disease events: the Health and Retirement Study, 2010-2022.

Health affairs scholar·2026
Same author

Layoff Experience in Adulthood and Premature Death Among US Working-Age Adults, 1979-2022.

American journal of public health·2026
Same author

Income Volatility During Early to Mid-adulthood and 10-year Memory Decline in a Longitudinal Synthetic Cohort.

Epidemiology (Cambridge, Mass.)·2026
Same author

Associations of alcohol use in early and middle adulthood with mid- and late-life cognition - a synthetic cohort approach.

medRxiv : the preprint server for health sciences·2026
Same author

Changes in financial well-being and memory function and decline in middle-aged and older adults.

American journal of epidemiology·2026
Same journal

Gut microbiota alterations in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.

Journal of Alzheimer's disease : JAD·2026
Same journal

Stage-dependent relationship between sleep duration and cortical tau deposition in cognitively impaired individuals: A cross-sectional study.

Journal of Alzheimer's disease : JAD·2026
Same journal

Multilayer brain connectivity and long-term cognitive changes in individuals at risk for Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026
Same journal

The creation and verification of a detection model for mild cognitive impairment by employing eye-tracking and gait metrics.

Journal of Alzheimer's disease : JAD·2026
Same journal

Compartment-specific analysis reveals disrupted astrocytic calcium transients in anesthetized Alzheimer's disease mice.

Journal of Alzheimer's disease : JAD·2026
Same journal

<i>APOE</i> ε4-specific associations between agitation, cerebrospinal fluid biomarkers, and cognitive decline in cognitively impaired patients.

Journal of Alzheimer's disease : JAD·2026
See all related articles

Related Experiment Video

Updated: Apr 21, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

17.1K

Arterial stiffness and cognitive function in the elderly.

Adina Zeki Al Hazzouri1, Kristine Yaffe2

  • 1Division of Epidemiology and Population Health, Department of Public Health Sciences, University of Miami, Miami, FL, USA.

Journal of Alzheimer'S Disease : JAD
|October 30, 2014
PubMed
Summary
This summary is machine-generated.

Arterial stiffness is linked to poorer cognitive function in older adults. While interventions show promise, more research is needed to confirm if reducing arterial stiffness can prevent cognitive decline and dementia.

Keywords:
Agingarterial stiffnesscognitive declinedementiaepidemiology

More Related Videos

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

17.8K
Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging
06:08

Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging

Published on: February 7, 2014

16.8K

Related Experiment Videos

Last Updated: Apr 21, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

17.1K
Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

17.8K
Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging
06:08

Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging

Published on: February 7, 2014

16.8K

Area of Science:

  • Gerontology
  • Neuroscience
  • Cardiovascular Science

Background:

  • Cognitive decline and dementia are significant health issues in older adults.
  • Observational studies link increased arterial stiffness to worse cognitive performance across various domains.
  • Evidence on arterial stiffness's impact on the rate of cognitive decline and dementia risk is less conclusive.

Purpose of the Study:

  • To review current research on the relationship between arterial stiffness and cognition.
  • To discuss measurement challenges and the potential impact of interventions on cognitive aging.
  • To highlight the need for further research into causal links and preventive strategies.

Main Methods:

  • Systematic review of existing epidemiological and observational studies.
  • Analysis of evidence regarding pharmacological and non-pharmacological interventions for arterial stiffness.
  • Identification of research gaps in evaluating interventions for cognitive health.

Main Results:

  • Cross-sectional data consistently associate higher arterial stiffness with poorer cognitive function.
  • Evidence is less definitive regarding the association between arterial stiffness and the rate of cognitive decline.
  • Promising, yet unevaluated, evidence exists for interventions targeting arterial stiffness in older adults.

Conclusions:

  • A clear association exists between arterial stiffness and cognitive performance.
  • Interventions for arterial stiffness are promising but require direct evaluation for their effect on cognitive impairment and dementia prevention.
  • Elucidating the causal link and testing interventions are crucial for improving cognitive health in the elderly.